JCI insight: Fatty acid receptor modulator PBI-4050 inhibits kidney fibrosis and improves glycemic control

June 20, 2019
Previous Flipbook
The Journal of Pharmacology: PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and
The Journal of Pharmacology: PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and

Next Flipbook
American Journal of Pathology: A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors GPR40 and GPR84
American Journal of Pathology: A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors GPR40 and GPR84